{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:34:47Z","timestamp":1760834087608,"version":"build-2065373602"},"reference-count":36,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,9,13]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Organ preservation is now considered an acceptable alternative option in distal rectal cancer patients with clinical complete response (cCR) after neoadjuvant chemoradiation (CRT). But the cCR rate is low and about one-third of tumour will regrow, which requires more effective local treatment. CRT combined with intra-arterial chemotherapy (IAC) might be a promising approach. Additionally, total neoadjuvant therapy using FOLFIRINOX induction chemotherapy improved survival while consolidation chemotherapy improved organ preservation. We assess whether IAC plus CRT and FOLFIRINOX consolidation chemotherapy can improve the chance of organ preservation and survival in distal rectal cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This prospective, monocentric, open-label, single-arm phase II study will include 32 patients with cT3-4NanyM0 distal rectal adenocarcinoma. All patients will receive one cycle of IAC (irinotecan, raltitrexed and oxaliplatin), followed by CRT (50\u2009Gy\/25 fractions with concomitant capecitabine) and then with six cycles of FOLFIRINOX (leucovorin, 5-fluorouracil, oxaliplatin and irinotecan). After final evaluation, patients with cCR will receive non-operative management or surgery at their own discretion and others are mandatorily referred to surgery. Adjuvant chemotherapy with six cycles of mFOLFOX6 (leucovorin, 5-fluorouracil and oxaliplatin) will be used for patients with adverse pathological features. The primary endpoint is the rate of complete response (CR; pathological CR or sustained cCR\u22652 years). The main secondary endpoints are toxicity, compliance, short-term and long-term oncological outcomes, surgical morbidity and quality of life. This protocol has been designed in accordance with the Standard Protocol Items: Recommendations for Interventional Trials 2013 guidelines.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>This study was approved by the Academic and Ethics Committee of The Affiliated Hospital of Youjiang Medical University for Nationalities in March 2023. Trial results will be published in peer-reviewed international journals and on the ChiCTR website.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Protocol version<\/jats:title>\n                  <jats:p>Registered on 18 April 2023; version #1.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>ChiCTR2300070620.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-075023","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T12:01:14Z","timestamp":1696507274000},"page":"e075023","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Single-arm, phase II study of intra-arterial chemotherapy plus total neoadjuvant therapy to optimise complete response in distal rectal cancer: a study protocol"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7405-3816","authenticated-orcid":false,"given":"Wenpeng","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Colon and Rectal Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Youjiang Medical University for Nationalities, Baise, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puda","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Colon and Rectal Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Youjiang Medical University for Nationalities, Baise, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houji","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Colon and Rectal Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Youjiang Medical University for Nationalities, Baise, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zanyi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Colon and Rectal Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Youjiang Medical University for Nationalities, Baise, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingwei","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Colon and Rectal Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Youjiang Medical University for Nationalities, Baise, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyu","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Colon and Rectal Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Youjiang Medical University for Nationalities, Baise, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Interventional Oncology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Youjiang Medical University for Nationalities, Baise, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yepeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Youjiang Medical University for Nationalities, Baise, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Youjiang Medical University for Nationalities, Baise, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Youjiang Medical University for Nationalities, Baise, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Youjiang Medical University for Nationalities, Baise, Guangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"2025101810164007000_13.10.e075023.1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0061"},{"key":"2025101810164007000_13.10.e075023.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70172-8"},{"key":"2025101810164007000_13.10.e075023.3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/bjs.1800700805","article-title":"The quality of life after Rectal Excision for low Rectal cancer","volume":"70","author":"Williams","year":"1983","journal-title":"Br J Surg"},{"key":"2025101810164007000_13.10.e075023.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00467-2"},{"key":"2025101810164007000_13.10.e075023.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.7176"},{"key":"2025101810164007000_13.10.e075023.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31078-X"},{"key":"2025101810164007000_13.10.e075023.7","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000141194.27992.32"},{"key":"2025101810164007000_13.10.e075023.8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0748-7983(97)92412-4","article-title":"Neoadjuvant intra-arterial polychemotherapy of locally advanced Rectal cancer","volume":"23","author":"Braun","year":"1997","journal-title":"Eur J Surg Oncol"},{"key":"2025101810164007000_13.10.e075023.9","first-page":"404","article-title":"Long-term results of preoperative regional Intraarterial chemotherapy against colorectal cancer","volume":"40","author":"Gu","year":"2002","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"2025101810164007000_13.10.e075023.10","first-page":"1247","article-title":"Preoperative intra-arterial chemotherapy for progressive lower Rectal cancer","volume":"28","author":"Tang","year":"2008","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"2025101810164007000_13.10.e075023.11","doi-asserted-by":"crossref","unstructured":"Yang B , Shan J , Feng Y , et al . Transcatheter Rectal arterial Chemoembolization with Oxaliplatin plus S-1 concurrent Chemoradiotherapy can improve the pathological remission rate in locally advanced Rectal cancer: a comparative study. Radiat Oncol 2020;15. doi:10.1186\/s13014-020-01540-4","DOI":"10.1186\/s13014-020-01540-4"},{"key":"2025101810164007000_13.10.e075023.12","first-page":"1423","article-title":"Influence and significance of preoperative Intraarterial infusion chemotherapy combined with radiotherapy on Survivin, P53 and BAX expression in low Rectal carcinoma","volume":"25","author":"Gan","year":"2006","journal-title":"Ai Zheng"},{"key":"2025101810164007000_13.10.e075023.13","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1159\/000502802","article-title":"Chemoradiotherapy with concurrent regional arterial chemotherapy for locally bulky Unresectable Rectal cancer: A case series","volume":"42","author":"Huang","year":"2019","journal-title":"Oncol Res Treat"},{"key":"2025101810164007000_13.10.e075023.14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70599-0"},{"key":"2025101810164007000_13.10.e075023.15","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00079-6"},{"key":"2025101810164007000_13.10.e075023.16","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with Rectal adenocarcinoma treated with total Neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"key":"2025101810164007000_13.10.e075023.17","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.5445","article-title":"Chemoradiotherapy plus induction or consolidation chemotherapy as total Neoadjuvant therapy for patients with locally advanced Rectal cancer: long-term results of the CAO\/ARO\/AIO-12 randomized clinical trial","volume":"8","author":"Fokas","year":"2022","journal-title":"JAMA Oncol"},{"key":"2025101810164007000_13.10.e075023.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00004-2"},{"key":"2025101810164007000_13.10.e075023.19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.clcc.2019.07.001","article-title":"Neoadjuvant chemotherapy with mFOLFOXIRI without routine use of radiotherapy for locally advanced Rectal cancer","volume":"18","author":"Zhang","year":"2019","journal-title":"Clinical Colorectal Cancer"},{"key":"2025101810164007000_13.10.e075023.20","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-003-0012-y"},{"key":"2025101810164007000_13.10.e075023.21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/DCR.0000000000000830","article-title":"Baseline T classification predicts early tumor regrowth after Nonoperative management in distal Rectal cancer after extended Neoadjuvant Chemoradiation and initial complete clinical response","volume":"60","author":"Habr-Gama","year":"2017","journal-title":"Dis Colon Rectum"},{"key":"2025101810164007000_13.10.e075023.22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3728"},{"key":"2025101810164007000_13.10.e075023.23","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1097\/PAS.0000000000001918","article-title":"DNA mismatch repair-deficient Rectal cancer is frequently associated with Lynch syndrome and with poor response to Neoadjuvant therapy","volume":"46","author":"Farchoukh","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"2025101810164007000_13.10.e075023.24","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"2025101810164007000_13.10.e075023.25","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"2025101810164007000_13.10.e075023.26","doi-asserted-by":"publisher","DOI":"10.1007\/BF02050307"},{"key":"2025101810164007000_13.10.e075023.27","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"2025101810164007000_13.10.e075023.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.08.014"},{"key":"2025101810164007000_13.10.e075023.29","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e3181a0a37e"},{"key":"2025101810164007000_13.10.e075023.30","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(89)90015-9"},{"key":"2025101810164007000_13.10.e075023.31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01667"},{"key":"2025101810164007000_13.10.e075023.32","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0071","article-title":"Adoption of total Neoadjuvant therapy for locally advanced Rectal cancer","volume":"4","author":"Cercek","year":"2018","journal-title":"JAMA Oncol"},{"key":"2025101810164007000_13.10.e075023.33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejca.2005.08.037","article-title":"A National Cancer Institute of Canada clinical trials group study--IND.135: phase I\/II study of Irinotecan (Camptosar) Oxaliplatin and Raltitrexed (Tomudex) (COT) in patients with advanced colorectal cancer","volume":"42","author":"Maroun","year":"2006","journal-title":"Eur J Cancer"},{"key":"2025101810164007000_13.10.e075023.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2011.07.030"},{"key":"2025101810164007000_13.10.e075023.35","first-page":"473","article-title":"Chinese expert consensus on the clinical application of the Chinese modified triplet combination with Irinotecan, Oxaliplatin and continuous Infusional 5-fluorouracil\/Leucovorin for colorectal cancer","volume":"24","year":"2021","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"key":"2025101810164007000_13.10.e075023.36","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1632-z","article-title":"Organ preservation in Rectal adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced Rectal cancer treated with Chemoradiation plus induction or consolidation chemotherapy, and total Mesorectal Excision or Nonoperative management","volume":"15","author":"Smith","year":"2015","journal-title":"BMC Cancer"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-075023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:16:51Z","timestamp":1760807811000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-075023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,5]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/bmjopen-2023-075023"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-075023","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}